Back to search

Article

Analysis of HIV-1 latent reservoir and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117

2018-05-25

Abstract excerpt

A clinical trial was performed to evaluate 3BNC117, a potent anti_HIV_1 antibody, in infected individuals during suppressive antiretroviral therapy (ART) and subsequent analytical treatment interruption (ATI). The circulating reservoir was evaluated by quantitative and qualitative outgrowth assay (Q 2 VOA) at entry and after 6 months, prior to ATI. Although there were no significant quantitative changes in the si...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2112ff24-98d1-5121-bb03-b96e381ef4a1
DOI
10.1101/324509
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analysis of HIV-1 latent reservoir and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117DOI 10.1101/324509
Select a neighboring publication to make it the new centre.